Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-01-11 Purchase |
2022-01-11 9:20 pm |
Vigil Neuroscience Inc. | VIGL | Thorp Clay Director |
265,000 | $14 | $3,710,000 | 1,519,335 (Indirect) |
View |
| 2022-01-11 Purchase |
2022-01-11 9:18 pm |
Vigil Neuroscience Inc. | VIGL | Vida Ventures GP III L.L.C. Vida Ventures III L.P. Vida Ventures III-A L.P. 10% Owner |
1,675,000 | $14 | $23,450,000 | 11,536 (Indirect) |
View |
| 2022-01-11 Purchase |
2022-01-11 9:15 pm |
Vigil Neuroscience Inc. | VIGL | Atlas Venture Fund XII L.P. Atlas Venture Associates XII L.P. Atlas Venture Associates XII LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner |
535,000 | $14 | $7,490,000 | 4,808,896 (Indirect) |
View |
| 2022-01-11 Purchase |
2022-01-11 9:11 pm |
Vigil Neuroscience Inc. | VIGL | Booth Bruce Director |
535,000 | $14 | $7,490,000 | 4,808,896 (Indirect) |
View |
| 2022-01-11 Purchase |
2022-01-11 9:11 pm |
Vigil Neuroscience Inc. | VIGL | Vitorovic Stefan Director |
1,675,000 | $14 | $23,450,000 | 11,536 (Indirect) |
View |
| 2022-01-11 Purchase |
2022-01-11 8:18 pm |
Vigil Neuroscience Inc. | VIGL | Northpond Ventures GP LLC Northpond Ventures LP Northpond Ventures GP II LLC Northpond Ventures II LP Rubin Michael P. 10% Owner |
355,000 | $14 | $4,970,000 | 1,382,978 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-01 Option Award |
2022-03-03 4:05 pm |
N/A 2032-03-01 |
Vigil Neuroscience Inc. | VIGL | Papapetropoulos Spyridon Chief Medical Officer |
75,500 | $0 | 75,500 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:05 pm |
N/A 2032-03-01 |
Vigil Neuroscience Inc. | VIGL | Thackaberry Evan SVP, Head of Early Development |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:05 pm |
N/A 2032-03-01 |
Vigil Neuroscience Inc. | VIGL | Blanchard Cheryl R Director |
5,017 | $9.63 | 5,017 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 4:05 pm |
N/A 2032-03-01 |
Vigil Neuroscience Inc. | VIGL | Ziolkowski Jennifer Lynn Chief Financial Officer |
110,000 | $0 | 110,000 (Direct) |
View |
| 2022-01-11 Conversion |
2022-01-13 4:06 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund IV LP Former 10% Owner |
616,786 | $0 | 616,786 (Indirect) |
View |
| 2022-01-11 Conversion |
2022-01-11 9:33 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | AMGEN INC 10% Owner |
3,206,281 | $0 | 3,206,281 (Direct) |
View |
| 2022-01-11 Conversion |
2022-01-11 9:20 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Thorp Clay Director |
4,732,862 | $0 | 1,519,335 (Indirect) |
View |
| 2022-01-11 Conversion |
2022-01-11 9:18 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Vida Ventures GP III L.L.C. Vida Ventures III L.P. Vida Ventures III-A L.P. 10% Owner |
12,605,995 | $0 | 11,536 (Indirect) |
View |
| 2022-01-11 Conversion |
2022-01-11 9:15 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Atlas Venture Fund XII L.P. Atlas Venture Associates XII L.P. Atlas Venture Associates XII LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner |
14,562,661 | $0 | 4,808,896 (Indirect) |
View |
| 2022-01-11 Conversion |
2022-01-11 9:11 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Booth Bruce Director |
14,562,661 | $0 | 4,808,896 (Indirect) |
View |
| 2022-01-11 Conversion |
2022-01-11 9:11 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Vitorovic Stefan Director |
12,605,995 | $0 | 11,536 (Indirect) |
View |
| 2022-01-11 Conversion |
2022-01-11 8:18 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Northpond Ventures GP LLC Northpond Ventures LP Northpond Ventures GP II LLC Northpond Ventures II LP Rubin Michael P. 10% Owner |
3,859,498 | $0 | 1,382,978 (Indirect) |
View |
| 2022-01-11 Conversion |
2022-01-11 5:53 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Alexandria Venture Investments LLC 10% Owner |
728,130 | $0 | 192,973 (Direct) |
View |
Ownership |
2022-01-06 8:54 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Vitorovic Stefan Director |
0 | $0 | 3,340,929 (Indirect) |
View |
Ownership |
2022-01-06 8:39 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | AMGEN INC 10% Owner |
0 | $0 | 3,206,281 (Direct) |
View |
Ownership |
2022-01-06 8:37 pm |
N/A 2030-11-18 |
Vigil Neuroscience Inc. | VIGL | Thackaberry Evan SVP, Head of Early Development |
0 | $0 | 148,019 (Direct) |
View |
Ownership |
2022-01-06 8:37 pm |
N/A 2030-11-18 |
Vigil Neuroscience Inc. | VIGL | Koenig Gerhard Director |
0 | $0 | 61,673 (Direct) |
View |
Ownership |
2022-01-06 8:34 pm |
N/A 2030-11-18 |
Vigil Neuroscience Inc. | VIGL | Blanchard Cheryl R Director |
0 | $0 | 61,674 (Direct) |
View |
Ownership |
2022-01-06 8:34 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Magovcevic-Liebisch Ivana President and CEO |
0 | $0 | 1,227,432 (Direct) |
View |
Ownership |
2022-01-06 8:34 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Thorp Clay Director |
0 | $0 | 1,254,335 (Indirect) |
View |
Ownership |
2022-01-06 8:31 pm |
N/A 2030-11-18 |
Vigil Neuroscience Inc. | VIGL | Papapetropoulos Spyridon Chief Medical Officer |
0 | $0 | 293,004 (Direct) |
View |
Ownership |
2022-01-06 8:30 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Booth Bruce Director |
0 | $0 | 5,301,874 (Indirect) |
View |
Ownership |
2022-01-06 8:30 pm |
N/A 2031-06-03 |
Vigil Neuroscience Inc. | VIGL | Ziolkowski Jennifer Lynn Chief Financial Officer |
0 | $0 | 287,577 (Direct) |
View |
Ownership |
2022-01-06 8:29 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Atlas Venture Fund XII L.P. Atlas Venture Associates XII L.P. Atlas Venture Associates XII LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner |
0 | $0 | 5,301,874 (Indirect) |
View |
Ownership |
2022-01-06 8:27 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Vida Ventures GP III L.L.C. Vida Ventures III L.P. Vida Ventures III-A L.P. 10% Owner |
0 | $0 | 3,340,929 (Indirect) |
View |
Ownership |
2022-01-06 7:31 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Alexandria Venture Investments LLC 10% Owner |
0 | $0 | 192,973 (Direct) |
View |
Ownership |
2022-01-06 4:42 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Northpond Ventures GP LLC Northpond Ventures LP Northpond Ventures GP II LLC Northpond Ventures II LP Rubin Michael P. 10% Owner |
0 | $0 | 3,859,498 (Indirect) |
View |
Ownership |
2022-01-06 4:28 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund IV LP 10% Owner |
0 | $0 | 616,786 (Indirect) |
View |